Logo image of SUZ

SUZANO SA - SPON ADR (SUZ) Stock Fundamental Analysis

NYSE:SUZ - New York Stock Exchange, Inc. - US86959K1051 - ADR - Currency: USD

8.925  +0.14 (+1.54%)

Fundamental Rating

5

Overall SUZ gets a fundamental rating of 5 out of 10. We evaluated SUZ against 9 industry peers in the Paper & Forest Products industry. SUZ has a medium profitability rating, but doesn't score so well on its financial health evaluation. SUZ has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year SUZ has reported negative net income.
SUZ had a positive operating cash flow in the past year.
In multiple years SUZ reported negative net income over the last 5 years.
In the past 5 years SUZ always reported a positive cash flow from operatings.
SUZ Yearly Net Income VS EBIT VS OCF VS FCFSUZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

1.2 Ratios

SUZ has a worse Return On Assets (-4.26%) than 66.67% of its industry peers.
SUZ has a worse Return On Equity (-21.91%) than 77.78% of its industry peers.
The Return On Invested Capital of SUZ (8.00%) is better than 77.78% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SUZ is in line with the industry average of 7.99%.
Industry RankSector Rank
ROA -4.26%
ROE -21.91%
ROIC 8%
ROA(3y)7.7%
ROA(5y)3.96%
ROE(3y)26.78%
ROE(5y)-2.15%
ROIC(3y)9.38%
ROIC(5y)9.39%
SUZ Yearly ROA, ROE, ROICSUZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

The Operating Margin of SUZ (30.45%) is better than 100.00% of its industry peers.
SUZ's Operating Margin has improved in the last couple of years.
SUZ has a better Gross Margin (42.19%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of SUZ has grown nicely.
Industry RankSector Rank
OM 30.45%
PM (TTM) N/A
GM 42.19%
OM growth 3Y-8.96%
OM growth 5Y26.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.3%
GM growth 5Y15.81%
SUZ Yearly Profit, Operating, Gross MarginsSUZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SUZ is destroying value.
SUZ has less shares outstanding than it did 1 year ago.
SUZ has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, SUZ has a worse debt to assets ratio.
SUZ Yearly Shares OutstandingSUZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
SUZ Yearly Total Debt VS Total AssetsSUZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

SUZ has an Altman-Z score of 1.09. This is a bad value and indicates that SUZ is not financially healthy and even has some risk of bankruptcy.
SUZ has a Altman-Z score of 1.09. This is in the lower half of the industry: SUZ underperforms 66.67% of its industry peers.
The Debt to FCF ratio of SUZ is 28.71, which is on the high side as it means it would take SUZ, 28.71 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 28.71, SUZ is doing good in the industry, outperforming 66.67% of the companies in the same industry.
SUZ has a Debt/Equity ratio of 3.01. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 3.01, SUZ is doing worse than 77.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.01
Debt/FCF 28.71
Altman-Z 1.09
ROIC/WACC0.74
WACC10.75%
SUZ Yearly LT Debt VS Equity VS FCFSUZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

A Current Ratio of 1.72 indicates that SUZ should not have too much problems paying its short term obligations.
The Current ratio of SUZ (1.72) is comparable to the rest of the industry.
SUZ has a Quick Ratio of 1.40. This is a normal value and indicates that SUZ is financially healthy and should not expect problems in meeting its short term obligations.
SUZ's Quick ratio of 1.40 is fine compared to the rest of the industry. SUZ outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.4
SUZ Yearly Current Assets VS Current LiabilitesSUZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

5

3. Growth

3.1 Past

The earnings per share for SUZ have decreased strongly by -151.20% in the last year.
Looking at the last year, SUZ shows a quite strong growth in Revenue. The Revenue has grown by 19.24% in the last year.
The Revenue has been growing by 12.75% on average over the past years. This is quite good.
EPS 1Y (TTM)-151.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-252.29%
Revenue 1Y (TTM)19.24%
Revenue growth 3Y4.99%
Revenue growth 5Y12.75%
Sales Q2Q%36.69%

3.2 Future

The Earnings Per Share is expected to grow by 54.62% on average over the next years. This is a very strong growth
SUZ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.08% yearly.
EPS Next Y273.7%
EPS Next 2Y89.79%
EPS Next 3Y54.62%
EPS Next 5YN/A
Revenue Next Year18.83%
Revenue Next 2Y13.77%
Revenue Next 3Y10.23%
Revenue Next 5Y8.08%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SUZ Yearly Revenue VS EstimatesSUZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B
SUZ Yearly EPS VS EstimatesSUZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 -10

6

4. Valuation

4.1 Price/Earnings Ratio

SUZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 5.21, the valuation of SUZ can be described as very cheap.
Based on the Price/Forward Earnings ratio, SUZ is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SUZ to the average of the S&P500 Index (20.49), we can say SUZ is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.21
SUZ Price Earnings VS Forward Price EarningsSUZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

77.78% of the companies in the same industry are more expensive than SUZ, based on the Enterprise Value to EBITDA ratio.
77.78% of the companies in the same industry are more expensive than SUZ, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.43
EV/EBITDA 5.69
SUZ Per share dataSUZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

SUZ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SUZ's earnings are expected to grow with 54.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y89.79%
EPS Next 3Y54.62%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.30%, SUZ has a reasonable but not impressive dividend return.
SUZ's Dividend Yield is a higher than the industry average which is at 2.90.
With a Dividend Yield of 1.30, SUZ pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.3%

5.2 History

On average, the dividend of SUZ grows each year by 20.94%, which is quite nice.
SUZ has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)20.94%
Div Incr Years0
Div Non Decr Years0
SUZ Yearly Dividends per shareSUZ Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

SUZ has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of SUZ is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-22.97%
EPS Next 2Y89.79%
EPS Next 3Y54.62%
SUZ Yearly Income VS Free CF VS DividendSUZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

SUZANO SA - SPON ADR

NYSE:SUZ (5/2/2025, 11:39:10 AM)

8.925

+0.14 (+1.54%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners29.42%
Inst Owner Change-0.71%
Ins Owners15.51%
Ins Owner ChangeN/A
Market Cap11.06B
Analysts81.9
Price Target13.99 (56.75%)
Short Float %0.58%
Short Ratio2.04
Dividend
Industry RankSector Rank
Dividend Yield 1.3%
Yearly Dividend0.23
Dividend Growth(5Y)20.94%
DP-22.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-267.86%
Min EPS beat(2)-569.87%
Max EPS beat(2)34.15%
EPS beat(4)2
Avg EPS beat(4)-191.18%
Min EPS beat(4)-569.87%
Max EPS beat(4)34.15%
EPS beat(8)5
Avg EPS beat(8)-83.59%
EPS beat(12)8
Avg EPS beat(12)-54.18%
EPS beat(16)12
Avg EPS beat(16)-30.88%
Revenue beat(2)1
Avg Revenue beat(2)2.17%
Min Revenue beat(2)-1.98%
Max Revenue beat(2)6.32%
Revenue beat(4)2
Avg Revenue beat(4)-0.61%
Min Revenue beat(4)-7.68%
Max Revenue beat(4)6.32%
Revenue beat(8)4
Avg Revenue beat(8)-0.58%
Revenue beat(12)7
Avg Revenue beat(12)-0.06%
Revenue beat(16)9
Avg Revenue beat(16)-0.64%
PT rev (1m)0.29%
PT rev (3m)8.96%
EPS NQ rev (1m)-31.43%
EPS NQ rev (3m)-44.24%
EPS NY rev (1m)3.08%
EPS NY rev (3m)31.11%
Revenue NQ rev (1m)3.25%
Revenue NQ rev (3m)1.81%
Revenue NY rev (1m)1.04%
Revenue NY rev (3m)7.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.21
P/S 1.31
P/FCF 16.43
P/OCF 3.01
P/B 1.92
P/tB 3.38
EV/EBITDA 5.69
EPS(TTM)-0.99
EYN/A
EPS(NY)1.71
Fwd EY19.18%
FCF(TTM)0.54
FCFY6.09%
OCF(TTM)2.96
OCFY33.2%
SpS6.82
BVpS4.64
TBVpS2.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.26%
ROE -21.91%
ROCE 10.21%
ROIC 8%
ROICexc 9.47%
ROICexgc 10.72%
OM 30.45%
PM (TTM) N/A
GM 42.19%
FCFM 7.97%
ROA(3y)7.7%
ROA(5y)3.96%
ROE(3y)26.78%
ROE(5y)-2.15%
ROIC(3y)9.38%
ROIC(5y)9.39%
ROICexc(3y)11.06%
ROICexc(5y)11.2%
ROICexgc(3y)12.82%
ROICexgc(5y)13.35%
ROCE(3y)11.96%
ROCE(5y)11.98%
ROICexcg growth 3Y-17.29%
ROICexcg growth 5Y26.8%
ROICexc growth 3Y-14.86%
ROICexc growth 5Y30.34%
OM growth 3Y-8.96%
OM growth 5Y26.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.3%
GM growth 5Y15.81%
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 3.01
Debt/FCF 28.71
Debt/EBITDA 4.1
Cap/Depr 182.44%
Cap/Sales 35.5%
Interest Coverage 2.75
Cash Conversion 87.08%
Profit Quality N/A
Current Ratio 1.72
Quick Ratio 1.4
Altman-Z 1.09
F-Score5
WACC10.75%
ROIC/WACC0.74
Cap/Depr(3y)212.09%
Cap/Depr(5y)160.32%
Cap/Sales(3y)37.3%
Cap/Sales(5y)28.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-151.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-252.29%
EPS Next Y273.7%
EPS Next 2Y89.79%
EPS Next 3Y54.62%
EPS Next 5YN/A
Revenue 1Y (TTM)19.24%
Revenue growth 3Y4.99%
Revenue growth 5Y12.75%
Sales Q2Q%36.69%
Revenue Next Year18.83%
Revenue Next 2Y13.77%
Revenue Next 3Y10.23%
Revenue Next 5Y8.08%
EBIT growth 1Y39.42%
EBIT growth 3Y-4.42%
EBIT growth 5Y42.3%
EBIT Next Year85.35%
EBIT Next 3Y28.77%
EBIT Next 5Y19.87%
FCF growth 1Y504.98%
FCF growth 3Y-30.27%
FCF growth 5Y9.93%
OCF growth 1Y18.99%
OCF growth 3Y5.32%
OCF growth 5Y22.15%